Skip to main content

Closed

BNGO: Bionano Genomics, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-7.4% / yr

Operating margin-114.0%

ROIC-60.0%

Financially safe

Stretched

Debt / equity0.45×

Interest coverage-114.6×

Current ratio1.84×

Bionano Genomics, Inc.

BNGONASDAQ Capital Market·USD·Closed

Bionano Genomics, Inc.

BNGONASDAQ·USD·Closed

$1.07

+0.94%

$1.07

+$0.01 (0.94%)

52W Range

2thpctl

Volume

1.66×avg

Mkt Cap

12.28MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

2thpctl

Volume

1.66×avg

Market Cap

12.28MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings